Afghanistan vs Côte d'Ivoire: Previously treated cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Côte d'Ivoire
100.0%
in 2024
Afghanistan rank
1st
Côte d'Ivoire rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Afghanistan
- Côte d'Ivoire
How they compare
Afghanistan currently reports 100.0% against 100.0% in Côte d'Ivoire, a difference of 0.0%.
The two have swapped places 4 times across 12 shared years of data; in 2010 it was Côte d'Ivoire ahead.
Afghanistan ranks 1st and Côte d'Ivoire ranks 1st of 180 countries.
Côte d'Ivoire has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Côte d'Ivoire | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.4% | 67.6% | 22.2% | Côte d'Ivoire |
| 2020s | 89.0% | 98.0% | 9.0% | Côte d'Ivoire |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Afghanistan or Côte d'Ivoire?
- Afghanistan, at 100.0% against 100.0% in Côte d'Ivoire as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Afghanistan and Côte d'Ivoire?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Côte d'Ivoire?
- 12 years are reported by both, from 2010 to 2024.
- How do Afghanistan and Côte d'Ivoire rank globally for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Côte d'Ivoire ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.